Change of hepatitis B virus activities with transcatheter arterial chemoembolization therapy in patients with HBV-related hepatocellular carcinoma.

被引：0
|
作者：
Park, KW [1 ]
Park, JW [1 ]
Cho, SH [1 ]
Park, HS [1 ]
Lee, WJ [1 ]
Kim, CM [1 ]
Lee, DH [1 ]
机构：
[1] Natl Canc Ctr, Goyang, South Korea
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：306A / 306A
页数：1
相关论文
共 50 条
  • [31] Quantitative analysis of plasma HBV DNA for early evaluation of the response to transcatheter arterial embolization for HBV-related hepatocellular carcinoma
    Sheng-Hsuan Chen
    Chin-Yuan Tzen
    World Journal of Gastroenterology, 2005, (39) : 6193 - 6196
  • [32] The variation of HBsAg titre in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma
    Pei, Y. Z.
    Han, T.
    Ma, X. Y.
    Li, Y.
    Xing, J.
    Song, Z. L.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S80 - S80
  • [33] Quantitative analysis of plasma HBV DNA for early evaluation of the response to transcatheter arterial embolization for HBV-related hepatocellular carcinoma
    Su, Ying-Wen
    Huang, Yu-Wen
    Chen, Sheng-Hsuan
    Tzen, Chin-Yuan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (39) : 6193 - 6196
  • [34] Hepatitis B Virus Reactivation Potential Risk Factors in Hepatocellular Carcinoma via Transcatheter Arterial Chemoembolization: A Retrospective Research
    Wang, Xiaoguang
    Yang, Xiaodan
    Chen, Fei
    Wu, Shaohan
    Song, Zhengwei
    Fei, Jianguo
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 2021
  • [35] Compartmentalisation of Hepatitis B virus X gene evolution in hepatocellular carcinoma microenvironment and the genotype-phenotype correlation of tumorigenicity in HBV-related patients with hepatocellular carcinoma
    Fu, Ya
    Fang, Fengling
    Guo, Hongyan
    Xiao, Xialin
    Hu, Yuhai
    Zeng, Yongbin
    Chen, Tianbin
    Wu, Songhang
    Lin, Ni
    Huang, Jinlan
    Jiang, Ling
    Ou, Qishui
    Liu, Can
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 2486 - 2501
  • [36] Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma
    Gao Heng-jun
    Zhang Yao-jun
    Chen Min-shan
    Chen Mei-xian
    Huang Jun-ting
    Xu Li
    Lau, Wan Y.
    LIVER INTERNATIONAL, 2014, 34 (04) : 612 - 620
  • [37] Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative
    Wang, Kai
    Jiang, Guomin
    Jia, Zhongzhi
    Zhu, Xiaoli
    Ni, Caifang
    MEDICINE, 2018, 97 (22)
  • [38] MORTALITY PREDICTION IN PATIENTS WITH HBV-RELATED HEPATOCELLULAR CARCINOMA
    Ji, Dong
    Chen, Song-Hai
    Wang, Yu-Dong
    Lu, Yiying
    Chen, Guofeng
    Lau, George
    HEPATOLOGY, 2021, 74 : 439A - 439A
  • [39] Antiviral therapy improves postoperative survival of patients with HBV-related hepatocellular carcinoma
    Guan, Ruo-Yu
    Sun, Bao-Ye
    Wang, Zhu-Tao
    Zhou, Cheng
    Yang, Zhang-Fu
    Gan, Wei
    Huang, Jin-Long
    Liu, Gao
    Zhou, Jian
    Fan, Jia
    Yi, Yong
    Qiu, Shuang-Jian
    AMERICAN JOURNAL OF SURGERY, 2022, 224 (01): : 494 - 500
  • [40] Hepatitis B virus and hepatocellular carcinoma.: Discussion
    Rérat, A
    Nordmann, R
    Bourel, M
    ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE, 1998, 34 (04): : 186 - 186
12345